Editorial: risk of loss of response to anti-TNFα agents in patients with inflammatory bowel disease-the longer the less?

被引：0
|
作者：
Goren, Idan [1 ,2 ]
Yanai, Henit [1 ,2 ]
机构：
[1] Rabin Med Ctr, Div Gastroenterol, IBD Ctr, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2022年 / 55卷 / 02期
关键词：
INFLIXIMAB; DRUG;
D O I：
10.1111/apt.16648
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：244 / 245
页数：2
相关论文
共 50 条
  • [11] Lower Therapeutic Response to Anti-TNF Agents in African Americans with Inflammatory Bowel Disease
    Owings, Anna H.
    Burstiner, Landen
    Royer, Amor
    Johnson, Jeshanah
    Barr, Madelyn
    Hreish, Yousef
    Bradley, Lauren
    Edwards, Kane
    Brar, Himmat
    Laird, Hannah
    Claggett, Brian
    Liu, Julia
    Glover, Sarah C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S326 - S327
  • [12] LOSS-OF-RESPONSE TO ANTI-TNFα CRITICALLY DEPENDS ON TREATMENT DURATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Schultheiss, Johannes P.
    Mahmoud, Remi
    Louwers, Jonas M.
    van der Kaaij, Michiel T.
    van Hellemondt, Boris P.
    van Boeckel, Petra G.
    Mahmmod, Nofel
    Jharap, Bindia
    Fidder, Herma H.
    Oldenburg, Bas
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S700 - S700
  • [13] Anti-TNF Treatment and Risk of Atrial Fibrillation in Inflammatory Bowel Disease Patients
    Cohen, Y.
    Fischman, M.
    Waterman, M.
    Dolnikov, K.
    Azzam, Z. S.
    Ghersin, I.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 681 - 681
  • [14] The efficiency of iron supplementation in inflammatory bowel disease patients treated with anti-TNF agents
    Kim, Su Young
    Kim, Yoon Jae
    Kim, Jung Ho
    Chung, Jun-Won
    Kwon, Kwang An
    Kim, Kyoung Oh
    Park, Dong Kyun
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 473 - 473
  • [15] Investigation of the effects of anti-TNF agents on hemoglobin levels in patients with inflammatory bowel disease
    Okuyucu, Muhammed
    Avcioglu, Ufuk
    Senel, Tugba
    Ustaoglu, Muge
    [J]. MEDICINE, 2022, 101 (35) : E30118
  • [16] Anti-TNF agents in patients with inflammatory bowel disease and malignant melanoma—challenges in management
    Jungmin Lee
    Kofi Clarke
    [J]. International Journal of Colorectal Disease, 2015, 30 : 1595 - 1602
  • [17] Are Thiopurines and Anti-TNFα Agents Safe to Use in Pregnant Patients With Inflammatory Bowel Disease?
    Sheibani, Sarah
    Mahadevan, Uma
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (03): : 441 - 443
  • [18] The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents
    Khan, Nabeel
    Trivedi, Chinmay
    Shah, Yash
    Patel, Dhruvan
    Lewis, James
    Yang, Yu-Xiao
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (06) : 1274 - 1279
  • [19] Induction of antiphospholipid antibodies in patients with inflammatory bowel disease treated with anti-TNFα agents
    Robles, V.
    deGuise, C. Herrera
    Guirola, M. A.
    Borruel, N.
    Casellas, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S254 - S255
  • [20] Fecal calprotectin in Inflammatory Bowel Disease treated with anti-TNF agents
    Marzo, M.
    Armuzzi, A.
    Felice, C.
    Forni, F.
    Papa, A.
    De Vitis, I
    Guidi, L.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S39 - S39
12345